BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 35032689)

  • 1. Exome sequencing identifies RASSF1 and KLK3 germline variants in an Iranian multiple-case breast cancer family.
    Radmanesh H; Liu D; Geffers R; Shandiz FH; Sadr-Nabavi A; Hillemanns P; Park-Simon TW; Dörk T
    Eur J Med Genet; 2022 Mar; 65(3):104425. PubMed ID: 35032689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family-specific, novel, deleterious germline variants provide a rich resource to identify genetic predispositions for BRCAx familial breast cancer.
    Wen H; Kim YC; Snyder C; Xiao F; Fleissner EA; Becirovic D; Luo J; Downs B; Sherman S; Cowan KH; Lynch HT; Wang SM
    BMC Cancer; 2014 Jun; 14():470. PubMed ID: 24969172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Germline Pathogenic Variant of
    Amin M; Mahmoodi-Khaledi E; Narrei S; Zeinalian M
    Iran J Med Sci; 2023 Jul; 48(4):420-424. PubMed ID: 37456212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study.
    Bubien V; Bonnet F; Dupiot-Chiron J; Barouk-Simonet E; Jones N; de Reynies A; MacGrogan G; Sevenet N; Letouzé E; Longy M
    Genes Chromosomes Cancer; 2017 Nov; 56(11):788-799. PubMed ID: 28691344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.
    Penney KL; Schumacher FR; Kraft P; Mucci LA; Sesso HD; Ma J; Niu Y; Cheong JK; Hunter DJ; Stampfer MJ; Hsu SI
    Carcinogenesis; 2011 Jun; 32(6):853-9. PubMed ID: 21421545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole exome sequencing identifies novel germline variants of SLC15A4 gene as potentially cancer predisposing in familial colorectal cancer.
    Skopelitou D; Srivastava A; Miao B; Kumar A; Dymerska D; Paramasivam N; Schlesner M; Lubinski J; Hemminki K; Försti A; Reddy Bandapalli O
    Mol Genet Genomics; 2022 Jul; 297(4):965-979. PubMed ID: 35562597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.
    Ellingson MS; Hart SN; Kalari KR; Suman V; Schahl KA; Dockter TJ; Felten SJ; Sinnwell JP; Thompson KJ; Tang X; Vedell PT; Barman P; Sicotte H; Eckel-Passow JE; Northfelt DW; Gray RJ; McLaughlin SA; Moreno-Aspitia A; Ingle JN; Moyer AM; Visscher DW; Jones K; Conners A; McDonough M; Wieben ED; Wang L; Weinshilboum R; Boughey JC; Goetz MP
    Breast Cancer Res Treat; 2015 Sep; 153(2):435-43. PubMed ID: 26296701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer.
    Park DJ; Odefrey FA; Hammet F; Giles GG; Baglietto L; ABCFS ; MCCS ; Hopper JL; Schmidt DF; Makalic E; Sinilnikova OM; Goldgar DE; Southey MC
    Breast Cancer Res Treat; 2011 Dec; 130(3):1043-9. PubMed ID: 21858661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome sequencing of Finnish hereditary breast cancer families.
    Määttä K; Rantapero T; Lindström A; Nykter M; Kankuri-Tammilehto M; Laasanen SL; Schleutker J
    Eur J Hum Genet; 2016 Jan; 25(1):85-93. PubMed ID: 27782108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
    Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
    Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer.
    Grant RC; Al-Sukhni W; Borgida AE; Holter S; Kanji ZS; McPherson T; Whelan E; Serra S; Trinh QM; Peltekova V; Stein LD; McPherson JD; Gallinger S
    Hum Genomics; 2013 Apr; 7(1):11. PubMed ID: 23561644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique Features of Germline Variation in Five Egyptian Familial Breast Cancer Families Revealed by Exome Sequencing.
    Kim YC; Soliman AS; Cui J; Ramadan M; Hablas A; Abouelhoda M; Hussien N; Ahmed O; Zekri AN; Seifeldin IA; Wang SM
    PLoS One; 2017; 12(1):e0167581. PubMed ID: 28076423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels.
    Parikh H; Wang Z; Pettigrew KA; Jia J; Daugherty S; Yeager M; Jacobs KB; Hutchinson A; Burdett L; Cullen M; Qi L; Boland J; Collins I; Albert TJ; Vatten LJ; Hveem K; Njølstad I; Cancel-Tassin G; Cussenot O; Valeri A; Virtamo J; Thun MJ; Feigelson HS; Diver WR; Chatterjee N; Thomas G; Albanes D; Chanock SJ; Hunter DJ; Hoover R; Hayes RB; Berndt SI; Sampson J; Amundadottir L
    Hum Genet; 2011 Jun; 129(6):675-85. PubMed ID: 21318478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
    Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L
    Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare MYC-N11S germline mutation indicative of inherited breast cancer in a multigeneration family.
    Budurlean L; Baker M; Broach J
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36368728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can unknown predisposition in familial breast cancer be family-specific?
    Lynch H; Wen H; Kim YC; Snyder C; Kinarsky Y; Chen PX; Xiao F; Goldgar D; Cowan KH; Wang SM
    Breast J; 2013; 19(5):520-8. PubMed ID: 23800003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational landscape of candidate genes in familial prostate cancer.
    Johnson AM; Zuhlke KA; Plotts C; McDonnell SK; Middha S; Riska SM; Schaid DJ; Thibodeau SN; Douglas JA; Cooney KA
    Prostate; 2014 Oct; 74(14):1371-8. PubMed ID: 25111073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.
    Franceschi S; Spugnesi L; Aretini P; Lessi F; Scarpitta R; Galli A; Congregati C; Caligo MA; Mazzanti CM
    Carcinogenesis; 2017 Sep; 38(9):938-943. PubMed ID: 28911001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
    Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
    Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome Sequencing in a Family with Luminal-Type Breast Cancer Underpinned by Variation in the Methylation Pathway.
    van der Merwe N; Peeters AV; Pienaar FM; Bezuidenhout J; van Rensburg SJ; Kotze MJ
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.